Cellectis is a publicly traded company trading on NASDAQ, led by CEO Andre Choulika.
Upcoming earnings announcement for Cellectis
Past 12 earnings reports for Cellectis
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Q4 2025 | -$0.24Est: -$0.10 | -140.0% | $12.2MEst: $10.7M | +13.7% | — |
| Nov 7, 2025 | Q3 2025 | $0.02Est: -$0.10 | +120.0% | $37.2MEst: $8.2M | +354.0% | — |
| Aug 4, 2025 | Q2 2025 | -$0.22Est: -$0.15 | -46.7% | $18.2MEst: $10.0M | +82.3% | — |
| May 12, 2025 | Q1 2025 | -$0.17Est: -$0.23 | +26.1% | $12.0MEst: $12.7M | -5.4% | — |
| Mar 13, 2025 | Q4 2024 | -$0.16Est: -$0.21 | +23.8% | $33.2MEst: $9.2M | +262.2% | — |
| Nov 4, 2024 | Q3 2024 | -$0.22Est: -$0.21 | -4.8% | $18.1MEst: $5.4M | +234.3% | — |
| Aug 6, 2024 | Q2 2024 | -$0.27Est: -$0.30 | +10.0% | $9.5MEst: $3.5M | +173.9% | — |
| May 28, 2024 | Q1 2024 | -$0.14Est: -$0.33 | +57.6% | $6.5MEst: $3.7M | +75.6% | — |
| Apr 29, 2024 | Q4 2023 | -$0.57Est: -$0.22 | -159.1% | $2.0MEst: $16.3M | -87.8% | — |
| Nov 6, 2023 | Q3 2023 | -$0.36Est: -$0.42 | +14.3% | $1.6MEst: $3.6M | -54.1% | — |
| Aug 3, 2023 | Q2 2023 | -$0.15Est: -$0.45 | +66.7% | $2.0MEst: $4.5M | -55.3% | — |
| May 4, 2023 | Q1 2023 | -$0.55Est: -$0.48 | -14.6% | $3.6MEst: $6.0M | -40.6% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.